67 related articles for article (PubMed ID: 2511112)
1. In vitro and in vivo effects of recombinant interferon gamma on the growth of hematopoietic progenitor cells from patients with myelodysplastic syndrome.
Rosti V; Carlo-Stella C; Pedrazzoli P; Cazzola M
Haematologica; 1989; 74(5):435-40. PubMed ID: 2511112
[TBL] [Abstract][Full Text] [Related]
2. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant interferons on human megakaryocyte growth.
Griffin CG; Grant BW
Exp Hematol; 1990 Oct; 18(9):1013-8. PubMed ID: 2118855
[TBL] [Abstract][Full Text] [Related]
4. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
5. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
[TBL] [Abstract][Full Text] [Related]
6. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
Lu L; Welte K; Gabrilove JL; Hangoc G; Bruno E; Hoffman R; Broxmeyer HE
Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.
Vey N; Viens P; Fossat C; Olive D; Sainty D; Baume D; Stoppa AM; Bouabdallah R; Brandely M; Gastaut JA; Maraninchi D; Blaise D
Eur Cytokine Netw; 1997 Dec; 8(4):389-94. PubMed ID: 9459619
[TBL] [Abstract][Full Text] [Related]
10. Amifostine promotes hemopoietic progenitor cell mobilization in patients with myelodysplastic syndrome.
Arboscello E; Botta M; Lerza R; Bogliolo G; Clavio M; Miglino M; Mencoboni M; Pannacciulli I
Anticancer Res; 2002; 22(3):1819-24. PubMed ID: 12168875
[TBL] [Abstract][Full Text] [Related]
11. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME; Wepsic HT
Exp Hematol; 1988 May; 16(4):295-301. PubMed ID: 2966070
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
14. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma induces differentiation of cells from patients with myelodysplastic syndromes in vitro and in vivo.
Yoshida Y
Leukemia; 1991 Sep; 5(9):796-8. PubMed ID: 1943231
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
Falk LA; Wahl LM; Vogel SN
J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
[TBL] [Abstract][Full Text] [Related]
20. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
